BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 31106933)

  • 1. Search for conditions to avoid parametrectomy during radical hysterectomy for cervical cancer.
    Ito F; Sugiura A; Toyoda S; Itani Y; Iwai K; Yamada Y; Tanase Y; Kawaguchi R; Kobayashi H; Kita T
    J Obstet Gynaecol Res; 2019 Jul; 45(7):1371-1375. PubMed ID: 31106933
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preoperatively Assessable Clinical and Pathological Risk Factors for Parametrial Involvement in Surgically Treated FIGO Stage IB-IIA Cervical Cancer.
    Canaz E; Ozyurek ES; Erdem B; Aldikactioglu Talmac M; Yildiz Ozaydin I; Akbayir O; Numanoglu C; Ulker V
    Int J Gynecol Cancer; 2017 Oct; 27(8):1722-1728. PubMed ID: 28617687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early cervical carcinoma: the natural history of lymph node involvement redefined on the basis of thorough parametrectomy and giant section study.
    Benedetti-Panici P; Maneschi F; D'Andrea G; Cutillo G; Rabitti C; Congiu M; Coronetta F; Capelli A
    Cancer; 2000 May; 88(10):2267-74. PubMed ID: 10820348
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Re-classification of uterine cervical cancer cases treated with radical hysterectomy based on the 2018 FIGO staging system.
    Osaku D; Komatsu H; Okawa M; Iida Y; Sato S; Oishi T; Harada T
    Taiwan J Obstet Gynecol; 2021 Nov; 60(6):1054-1058. PubMed ID: 34794737
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Long-term oncological outcomes after laparoscopic versus abdominal radical hysterectomy in stage I a2- II a2 cervical cancer: a matched cohort study].
    Wang W; Shang C; Huang J; Chen S; Shen H; Yao S
    Zhonghua Fu Chan Ke Za Zhi; 2015 Dec; 50(12):894-901. PubMed ID: 26887872
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of stages IB1 and IB2 cervical cancers treated with radical hysterectomy. Is size the real difference?
    Rutledge TL; Kamelle SA; Tillmanns TD; Gould NS; Wright JD; Cohn DE; Herzog TJ; Rader JS; Gold MA; Johnson GA; Walker JL; Mannel RS; McMeekin DS
    Gynecol Oncol; 2004 Oct; 95(1):70-6. PubMed ID: 15385112
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Para-aortic lymph node involvement revisited in the light of the revised 2018 FIGO staging system for cervical cancer.
    Ayhan A; Aslan K; Öz M; Tohma YA; Kuşçu E; Meydanli MM
    Arch Gynecol Obstet; 2019 Sep; 300(3):675-682. PubMed ID: 31263988
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radical hysterectomy with or without para-aortic lymphadenectomy for patients with stage IB2, IIA2, and IIB cervical cancer: outcomes for a series of 308 patients.
    Tsuruga T; Fujimoto A; Kawana K; Mori M; Hasumi Y; Kino N; Tomio K; Miura S; Tanikawa M; Sone K; Miyamoto Y; Ikeda Y; Kojima S; Adachi K; Nagasaka K; Matsumoto Y; Arimoto T; Oda K; Nakagawa S; Horie K; Yasugi T; Yokota H; Osuga Y; Fujii T
    Int J Clin Oncol; 2016 Apr; 21(2):359-366. PubMed ID: 26438230
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors predicting parametrial invasion in patients with early-stage cervical carcinomas.
    Hsu HC; Tai YJ; Chen YL; Chiang YC; Chen CA; Cheng WF
    PLoS One; 2018; 13(10):e0204950. PubMed ID: 30335786
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Robotic Radical Parametrectomy With Upper Vaginectomy and Pelvic Lymphadenectomy in Patients With Occult Cervical Carcinoma After Extrafascial Hysterectomy.
    Tran AQ; Sullivan SA; Gehrig PA; Soper JT; Boggess JF; Kim KH
    J Minim Invasive Gynecol; 2017; 24(5):757-763. PubMed ID: 28254677
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Can pelvic lymphadenectomy be omitted in stage IA2 to IIB uterine cervical cancer?
    Togami S; Kamio M; Yanazume S; Yoshinaga M; Douchi T
    Int J Gynecol Cancer; 2014 Jul; 24(6):1072-6. PubMed ID: 24905616
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictive Factors of Pelvic Lymph Node Metastasis in Early-Stage Cervical Cancer.
    Nanthamongkolkul K; Hanprasertpong J
    Oncol Res Treat; 2018; 41(4):194-198. PubMed ID: 29562222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intratumoral lymphatic vessel density and clinicopathologic features of patients with early-stage cervical cancer after radical hysterectomy.
    Zaganelli FL; Carvalho FM; Almeida BG; Bacchi CE; Goes JC; Calil MA; Baracat EC; Carvalho JP
    Int J Gynecol Cancer; 2010 Oct; 20(7):1225-31. PubMed ID: 21135594
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Number of Removed Pelvic Lymph Nodes as a Prognostic Marker in FIGO Stage IB1 Cervical Cancer with Negative Lymph Nodes.
    Wang R; Tao X; Wu X; Jiang H; Xia H
    J Minim Invasive Gynecol; 2020; 27(4):946-952. PubMed ID: 31394263
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Topographic distribution of lymph node metastasis in patients with stage IB1 cervical cancer: an analysis of 8314 lymph nodes.
    Cai J; He X; Wang H; Dong W; Zhang Y; Zhao J; Willborn KC; Huang B; Wang Z; Jiang P
    Radiat Oncol; 2021 Mar; 16(1):54. PubMed ID: 33743714
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Magnetic Resonance Imaging as a Valuable Tool for Predicting Parametrial Invasion in Stage IB1 to IIA2 Cervical Cancer.
    Kim M; Suh DH; Kim K; Lee HJ; Kim YB; No JH
    Int J Gynecol Cancer; 2017 Feb; 27(2):332-338. PubMed ID: 28114236
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors associated with parametrial involvement in stage IB1 cervical cancer and identification of patients suitable for less radical surgery.
    Kodama J; Kusumoto T; Nakamura K; Seki N; Hongo A; Hiramatsu Y
    Gynecol Oncol; 2011 Sep; 122(3):491-4. PubMed ID: 21703671
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intra-operative frozen section analysis of common iliac lymph nodes in patients with stage IB1 and IIA1 cervical cancer.
    Lv X; Chen L; Yu H; Zhang X; Yan D
    Arch Gynecol Obstet; 2012 Mar; 285(3):811-6. PubMed ID: 21837427
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Utility of parametrectomy for early stage cervical cancer treated with radical hysterectomy.
    Wright JD; Grigsby PW; Brooks R; Powell MA; Gibb RK; Gao F; Rader JS; Mutch DG
    Cancer; 2007 Sep; 110(6):1281-6. PubMed ID: 17654664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multivariate analysis of histopathologic prognostic factors for invasive cervical cancer treated with radical hysterectomy and systematic retroperitoneal lymphadenectomy.
    Takeda N; Sakuragi N; Takeda M; Okamoto K; Kuwabara M; Negishi H; Oikawa M; Yamamoto R; Yamada H; Fujimoto S
    Acta Obstet Gynecol Scand; 2002 Dec; 81(12):1144-51. PubMed ID: 12519111
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.